跳至主要内容
临床试验/CTRI/2021/03/032449
CTRI/2021/03/032449尚未招募未知

A Randomized controlled clinical trial to evaluvate the efficacy between GomutraTriphala Vati and Atorvastatin in the management of Medovruddhi in Sthaulya with special reference to Hyperlipidemia

PDEAs College of Ayurved and Research Centre NigdiPune0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1Patients suffering from Medovruddhijanit symptoms in Sthaulya.
  • 2Patients who are having two or more following symptoms will be included for the study
  • 1 SHWASADHIKYA
  • 2 NIDRADHIKYA
  • 3 AAYAS AKSHAMATA
  • 5 BALAHEENATA
  • 6 ATI KSHUDHA
  • 7 ATI TRUSHNA
  • 3Age group having 25 to 65 years age,irrespective of any gender,socio economic status and religion.
  • 4B.M.I 25.0 to 35 kg/m2.
  • 5Patient having Serum Total Cholesterol Level more than 200mg/dl 6Patient having Serum Triglyceride Level more than 150mg/dl

排除标准

  • 1Pregnant and Lactating women.
  • 2Known cases of Uncontrolled Diabetes Mellitus with Its Complications.
  • 3Known cases of Major systemic diseases such as TB,AIDS,IHD,CA,Renal and Cerebral diseases.
  • 4Known cases of Acute complications like Coronary Heart Disease,Hepatitis.
  • 5High risk (above 65 yrs age,known cases of HTN,DM,COPD)
  • 6Comorbid patients Suspected for Covid-19. Suspected Covid-19 patients having symptoms as per ICMR guidelines.

研究者

发起方
PDEAs College of Ayurved and Research Centre NigdiPune

相似试验